close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar48000Point52
Implied share price

Buy Undervalued by 240002500.0%

5% margin of safety What's this?

EV / Revenue
Use Average
OSCI
Oscient Pharmaceuticals Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
AMGN
Amgen, Inc.
Change
AGN
Allergan, Inc.
Change
21795.41 2.13 27840.41 3.07 4.99 9.4
All amounts in millions
from last financial year
         
Implied Share Price $48000.52 $48907.21 $490963.86 $626169.79 $722316.58
Market Cap 0 1,229,412 125,743 107,989 107,335
Net Debt 184 20 -26,208 174 15,514
Enterprise Value (EV) 185 1,229,432 100,217 108,116 122,849
Revenue 86 44 32,639 21,662 13,062
Balance Sheet          
Total Assets 174 58 51,839 71,576 52,758
Total Liabilities 255 56 32,724 43,493 24,426
Shareholders Equity -81 2 19,115 28,083 28,331.1

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.